CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
CRMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.53%149.630.7%$1822.06m
MDTMedtronic Plc
0.62%111.730.6%$500.02m
TMOThermo Fisher Scientific, Inc.
0.08%317.351.0%$366.52m
ABTAbbott Laboratories
0.44%84.930.8%$361.79m
ISRGIntuitive Surgical, Inc.
-0.10%574.792.4%$316.75m
BDXBecton, Dickinson & Co.
1.50%261.111.1%$299.11m
EWEdwards Lifesciences Corp.
0.53%230.381.2%$287.40m
SYKStryker Corp.
-0.06%198.011.3%$258.78m
BSXBoston Scientific Corp.
-0.43%43.821.1%$250.38m
BAXBaxter International, Inc.
0.88%83.011.8%$206.13m
DXCMDexCom, Inc.
-1.47%212.368.3%$204.63m
PODDInsulet Corp.
1.12%180.196.7%$160.58m
MTDMettler-Toledo International, Inc.
1.16%762.935.4%$158.47m
ALGNAlign Technology, Inc.
0.58%275.236.4%$146.22m
HOLXHologic, Inc.
0.77%52.601.7%$145.35m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.